Related Experiment Videos
LVAD power delivery: a percutaneous approach to avoid infection
R Jarvik1, S Westaby, T Katsumata
1Oxford Heart Centre, John Radcliffe Hospital, United Kingdom.
The Annals of Thoracic Surgery
|March 4, 1998
Summary
To prevent driveline infections in patients with left ventricular assist devices (LVADs), researchers developed a skull-mounted pedestal. This innovative approach using rigid fixation and scalp skin significantly reduced infection and healing complications in a sheep model.
Area of Science:
- Biomedical Engineering
- Cardiovascular Surgery
- Infectious Disease Prevention
Background:
- Driveline infections are a major complication for patients with left ventricular assist devices (LVADs), impacting their survival.
- Reducing driveline complications is crucial for improving LVAD therapy, especially for bridge-to-transplantation or recovery.
Purpose of the Study:
- To develop and evaluate a novel pedestal design to minimize percutaneous driveline infections in LVAD patients.
- To assess the efficacy of a skull-mounted pedestal compared to a shoulder-mounted one in a preclinical model.
Main Methods:
- A carbon and later titanium pedestal was designed to route electric wires through the skin in a sheep model.
- Pedestals were implanted in the shoulder (n=10) or scalp with skull fixation (n=9), with exit wounds monitored for infection and healing.
- Power cable durability was tested in 6 additional animals without implanted pumps.
Main Results:
- Skull-mounted pedestals showed no infection or healing issues over a cumulative 1,491 days.
- Shoulder-mounted pedestals in mobile tissues resulted in infection (n=2) and impaired healing (n=5).
- Electric cables demonstrated durability during repeated neck flexion, and titanium pedestals proved more robust than carbon ones.
Conclusions:
- Rigid fixation combined with highly vascularized scalp skin effectively reduces percutaneous driveline infections.
- This novel pedestal design offers a potential solution to a significant challenge in long-term LVAD therapy.